Summary:
Efficacy, Immunogenicity and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection.
Have you been hospitalized two or more times in the past year and have taken antibiotics? Do you have a scheduled hospital stay for several days?
Could you be at risk for C. difficile infection?
Sanofi and this research site are conducting a clinical research study to find out if an investigational vaccine can protect at-risk individuals like yourself from Clostridium difficile (c.diff) infections.
Qualified Participants Must:
• Be 50 years of age or older